
Dr. Mitch Rosenthal on the Recent Changes in Oregon

Dr Mitch Rosenthal on Ballot Initiative Results Across the Country

Dr. Mitch Rosenthal on Marijuana Legalization

Dr. Mitch Rosenthal on the Terrible Purdue Pharma and Sackler Family Settlement

Dr. Mitch Rosenthal on the Dire State of Drug Rehabilitation Treatment in New York

Dr. Mitch Rosenthal on the Lack of a Strong Drug Czar in Washington

Dr. Mitch Rosenthal on the Importance of Focusing on the Opioid Epidemic

Dr. Mitch Rosenthal on the Impact of the Supreme Court on Battling the Opioid Crisis

Dr. Mitch Rosenthal on the Impact of Coronavirus on Addiction

Dr. Mitch Rosenthal on Vaping Use Statistics Among Adolescents

Dr. Mitch Rosenthal on Increasing Marijuana Use Statistics

Dr. Mitch Rosenthal on Pennsylvania Legalization Plans

Dr. Mitch Rosenthal Voices Support for the Biden/Harris Drug Rehabilitation Plan

Dr. Mitch Rosenthal on the FDA's Lack of Efforts to Combat Teen Vaping

Dr. Mitch Rosenthal on Concerns About Home Delivery of Marijuana in California

Dr. Mitch Rosenthal on the Need for Communities of Color to be Represented in Opioid Litigation

Dr. Mitch Rosenthal on Concerning Data Coming out of Colorado

Dr. Mitch Rosenthal on the Need to Incorporate Treatments with Safe Injection Sites

Dr. Mitch Rosenthal on the Lack of Attention to the Addiction Crisis

Dr. Mitch Rosenthal on Gov. Cuomo's Proposed Cuts to Addiction and Recovery Services

Dr. Mitch Rosenthal on Vice President Biden's Marijuana Policies

2020 Rosenthal Center Cannabis Perceptions Poll

Dr. Mitch Rosenthal on the Perspectives of Marijuana Legalization in the Democratic Primary

Dr. Mitch Rosenthal on Politicians' Lack of Attention to the Opioid Crisis

Dr. Mitch Rosenthal on the Realities of the Opioid Crisis
Click here for video

Dr. Mitch Rosenthal on the Trump Administration Backpedaling on Vaping

Dr. Mitch Rosenthal on the FDA's Lackluster Response to the Vaping Crisis
Click here for video.

Dr. Mitch Rosenthal on the Lack of Progress in Combatting the Opioid Crisis

Dr. Mitch Rosenthal on the Need for $100 Billion to Combat Addiction and Support Recovery

Dr. Mitch Rosenthal on the Need for National Laws That Prevent Vaping

Dr. Mitchell Rosenthal on President Trump's Decision to Back Away from a Flavored E Cigarette Ban

Dr. Mitch Rosenthal Proposes Changes to Safe Injection Sites

Dr. Mitch Rosenthal on the Need to Support a FDA Ban on Flavored E Cigarettes

Dr Mitch Rosenthal on the Need to Ban Vaping Across the Entire Country

Dr. Mitchell Rosenthal on Upcoming Opioid Litigation Cases this Month

Dr. Mitchell Rosenthal on the Need to Stop Vaping Nationally

Dr. Mitch Rosenthal on the Need to Follow Massachusetts' Lead on Banning All Vaping Products

Dr. Mitch Rosenthal on the Dangers and Risks Associated with Vaping

Dr. Mitch Rosenthal on the Dangers of Vaping

Dr. Mitch Rosenthal on the Federal Government's Move to Ban Flavored E Cigarettes

Dr. Mitch Rosenthal on the Dangers of New & Powerful Marijuana that is Available

Dr. Mitch Rosenthal on the Need for Any Opioid Crisis Settlement to Focus on Treatment

Dr. Mitch Rosenthal on the Risks of Overprescribing Opioids to Children for Tonsillectomy

Dr. Mitch Rosenthal on the Lack of Attention to the Opioid Crisis in the Current Political Discussion

Dr Mitch Rosenthal on the Need for Comprehensive Action Plans to Combat the Opioid Crisis

Dr Mitch Rosenthal on the Susceptibility of the Adolescent Brain to Drugs and Addiction

Dr Mitch Rosenthal on the Overprescription of Opioid Medication in the United States

Dr. Mitch Rosenthal on the Need to Emulate Effective Overdose Prevention Programs from Dayton, Ohio

New Opioid Taxes & Employer-based Solutions to the Opioid Epidemic

Dr. Mitch Rosenthal's Good Day NY Addiction and Best Treatment Practices Segment

President Trump Lacks Opioid Crisis Strategy

Gottlieb's Disappointing Departure from FDA

Reckless Pursuit of Marijuana Legalization and Commercialization

We Need Treatment Funding, Not a Border Wall, to Solve Drug Crisis

VIDEO on Alex Berenson's Book, Tell Your Children

It's Time to Rethink Our National Drug Policy

Dayton's Successful Strategies to Address Opioids

President Trump: don’t gut the budget of the White House Office of National Drug Control Policy!
Slashing spending to just $24 million from $388 million will harm nation-wide efforts to fight the deadly opioid epidemic.
ONDCP oversees essential drug programs and integrates critical government resources. Don’t be penny wise and pound foolish!

President Trump: don’t gut the budget of the White House Office of National Drug Control Policy!
Slashing spending to just $24 million from $388 million will harm nation-wide efforts to fight the deadly opioid epidemic.
ONDCP oversees essential drug programs and integrates critical government resources. Don’t be penny wise and pound foolish!

Tell the President:
DON’T dump the Drug Czar
DO save the ONDCP
Drug overdose kills more than 52,000 Americans a year—more than cancer, more than auto accidents.
A cohesive national anti-addiction policy is essential.
But the Office of Drug Control Policy (ONDCP), the part of your White House that oversees
the nation’s anti-drug efforts, is on the hit list of the Budget Office, along with PBS, Americorps, and the National Endowments.
Eliminating ONDCP will save roughly $25 million for salaries, expenses, and policy research, and denyabout $350 million to critical drug control programs.
This is penny wisdom and pound folly at its worst.
-Mitchell S. Rosenthal, MD
President

Tell the President:
DON’T dump the Drug Czar
DO save the ONDCP
Drug overdose kills more than 52,000 Americans a year—more than cancer, more than auto accidents.
A cohesive national anti-addiction policy is essential.
But the Office of Drug Control Policy (ONDCP), the part of your White House that oversees
the nation’s anti-drug efforts, is on the hit list of the Budget Office, along with PBS, Americorps, and the National Endowments.
Eliminating ONDCP will save roughly $25 million for salaries, expenses, and policy research, and denyabout $350 million to critical drug control programs.
This is penny wisdom and pound folly at its worst.
-Mitchell S. Rosenthal, MD
President